Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: A novel approach to monitoring the efficacy of anti-tumor treatments in animal models: combining functional MRI and texture analysis

Fig. 1

The tumor growth trends in the three groups. a The axial T2WI images of pre-treatment and after 7- and 15-day treatment with different therapies. The tumors became larger in the whole process and grew most quickly in the control group, which caused the surrounding organs to be constricted severely at the end of this trial. However, the combination group showed the slowest growth and the tumors remained relatively small and shallow in the late phases of treatment. The growth rate in the paclitaxel group was somewhere in the middle. b The percentage change of the tumor volume. The tumors exhibited nearly linear growth in the control group. There was no significant difference among the three groups on day 7 after therapy (P = 0.60). However, at the end of treatment, tumor growth was obviously suppressed by paclitaxel with bevacizumab combined therapy compared to the control group on day 15 (P = 0.018)

Back to article page